China approves two more domestic Covid-19 vaccines, increasing number to 4

Published on Feb 25, 2021 08:47 PM IST

The two newly approved vaccines are made by CanSino Biologics Inc and Wuhan Institute of Biological Products, an affiliate of China National Pharmaceutical Group (Sinopharm).

FILE - In this Sept. 24, 2020, file photo, a worker inspects syringes of a vaccine for COVID-19 produced by Sinovac at its factory in Beijing. China approved two new more COVID-19 vaccines for wider use Thursday, adding to its growing arsenal of shots: one from CanSino Biologics, and a second one from state-owned Sinopharm. (AP Photo/Ng Han Guan, File)(AP)
FILE - In this Sept. 24, 2020, file photo, a worker inspects syringes of a vaccine for COVID-19 produced by Sinovac at its factory in Beijing. China approved two new more COVID-19 vaccines for wider use Thursday, adding to its growing arsenal of shots: one from CanSino Biologics, and a second one from state-owned Sinopharm. (AP Photo/Ng Han Guan, File)(AP)
Reuters |

China's National Medical Products Administration said on Thursday that it had approved two more Covid-19 vaccines for public use, increasing the number of domestic vaccines approved in China to four.

The two newly approved vaccines are made by CanSino Biologics Inc and Wuhan Institute of Biological Products, an affiliate of China National Pharmaceutical Group (Sinopharm).

They join a vaccine from Sinovac Biotech approved earlier this month, and another from Sinopharm's Beijing unit approved last year.

So far, China has not approved Covid-19 vaccines developed by Western drug makers.

Sinopharm's Wuhan unit said on Wednesday its vaccine had an efficacy rate of 72.51% against the Covid-19 disease caused by the virus, citing interim analysis of late-stage clinical trial data, without offering more details.

It is one of two candidates from Sinopharm that have entered Phase III clinical trials overseas, and was earlier given to a limited group of people at higher infection risk.

The four approved Chinese vaccines can be stored at normal freezer temperatures, making them a potentially attractive option for developing countries which might have difficulty deploying vaccines from Pfizer and Moderna that require much colder temperatures for longer-term storage.

China has been exporting the Sinovac and earlier Sinopharm vaccines to countries around the world.


Get Latest World Newsalong with Latest Newsfrom Indiaat Hindustan Times.
SHARE THIS ARTICLE ON
SHARE
Story Saved
×
Saved Articles
Following
My Reads
My Offers
Sign out
New Delhi 0C
Tuesday, November 29, 2022
Start 15 Days Free Trial Subscribe Now
Register Free and get Exciting Deals